-- Sun Pharmaceutical Climbs After Second-Quarter Net Tops Analysts Estimates
-- B y   H a r i   G o v i n d
-- 2010-11-01T03:48:01Z
-- http://www.bloomberg.com/news/2010-11-01/sun-pharmaceutical-climbs-after-second-quarter-net-tops-analysts-estimates.html
Sun Pharmaceutical Industries Ltd.,
India’s biggest drugmaker by market value, 
rose in Mumbai after
reporting second-quarter profit rose 12 percent, beating
analysts’ estimates, on higher demand for generic medicines.  The shares climbed as much as 3.3 percent and changed hands
at 2,170.1 rupees at 9:16 a.m. local time.  Net income increased to 5.04 billion rupees ($113 million)
in the three months ended Sept. 30 from 4.5 billion rupees a
year earlier, the Mumbai-based company said in a statement Oct.
30.  To contact the editor responsible for this story:
Hari Govind at 
 hgovind@bloomberg.net  